Postmenopausal Osteopenia Clinical Trial
— TRAMBONEOfficial title:
Sport and Prevention of Bone Resorption
Verified date | June 2021 |
Source | University of Palermo |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of the project is to study the effects on bone remodeling induced by training carried out with the trampoline in order to evaluate the reduction of the resorption itself and therefore the onset of osteoporosis in women.
Status | Completed |
Enrollment | 40 |
Est. completion date | March 3, 2020 |
Est. primary completion date | January 31, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 55 Years |
Eligibility | Inclusion Criteria: - Caucasian - age: 18-55 years - currently injury free - Body mass index between 18.5 and 28 kg/m2 Exclusion Criteria: - bone fracture within the previous year - use of medication or suffering from any condition known to affect bone metabolism - pregnancy - breastfeeding - current smokers - participation in moderate and high impact-activity for =3 h·week before enrolling the study. |
Country | Name | City | State |
---|---|---|---|
Italy | Sport and Exercise Research Unit, Palermo University | Palermo |
Lead Sponsor | Collaborator |
---|---|
University of Palermo |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Serum bone remodelling markers | bone resorption CTX and bone formation osteocalcin will be assessed at baseline and after 20weeks | 20 WEEKS | |
Primary | Serum bone matabolism markers | PTH, calcitonin, Vitamin D, Calcium, Phosphate, Potassium will be assessed at baseline and after 20weeks | 20 WEEKS | |
Primary | Plasma concentrations of Gastrointestinal peptides | GLP-1, GLP-2, GIP, PYY, Ghrelin will be assessed at baseline and after 20weeks | 20 WEEKS | |
Secondary | body mass index (BMI) | Weight (Kg)
Hight (m) BMI (kg/m2) All these measurements will be assessed at baseline and after 20weeks |
20 WEEKS | |
Secondary | body composition | lean mass as percent of body weight and fat mass as percent of body weight will be assessed at baseline and after 20weeks | 20 WEEKS | |
Secondary | insulin | measured in plasma will be assessed at baseline and after 20 weeks | 20 WEEKS | |
Secondary | glucose | measured in plasma will be assessed at baseline and after 20 weeks | 20 WEEKS | |
Secondary | triglicerises | measured in plasma will be assessed at baseline and after 20 weeks | 20 WEEKS | |
Secondary | HDL | measured in plasma will be assessed at baseline and after 20 weeks | 20 WEEKS | |
Secondary | Cholesterol | measured in plasma will be assessed at baseline and after 20 weeks | 20 WEEKS |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04862910 -
Effects of Kinect-based Virtual Reality Training in Postmenopausal Women With Osteopenia
|
N/A | |
Completed |
NCT04653350 -
High Intensity Multi-Modal Exercise Training in Postmenopausal Women
|
N/A | |
Active, not recruiting |
NCT05348694 -
OsteoPreP: Food Supplements for Postmenopausal Bone Health
|
Phase 4 | |
Completed |
NCT04873960 -
Translation and Cross -Cultural Validation of ECOS-16 Questionnaire in Urdu Language
|
||
Completed |
NCT05421819 -
Design and Development of a Novel Food Supplement for Osteoporosis Based on Gut Microbiome Mechanisms
|
N/A | |
Completed |
NCT03999775 -
Effect of Calcium and Vitamin D Supplementation With and Without Collagen Peptides in Postmenopausal Women With Osteopenia
|
N/A |